December 06, 2024

Trastuzumab Duocarmazine in Previously Treated HER2-Positive Metastatic Breast Cancer

In the phase III TULIP trial reported in the Journal of Clinical Oncology, Turner et al found that the third-generation HER2-targeted antibody-drug conjugate trastuzumab duocarmazine improved progress...

The ASCO Post

November 19, 2024

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults vs Older Adults?

Young patients living with colon or colorectal cancer have long-term, adverse consequences on their lives, which are different from the impact the disease has on older adults, according to two studies...

The ASCO Post

November 14, 2024

From Gaps to Bridges: Cancer Care Rooted in Equity, Quality, and Value

“Inequities are a major obstacle in delivering safe, timely, respectful, and affordable cancer care globally,” commented moderator John Varallo, MD, MPH, FACOG, of the Global Surgery Foundation, at th...

The ASCO Post

July 01, 2023

GUEST EDITORIAL

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

October 01, 2023

CLINICAL TRIAL DOWNLOAD

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Retinal Physician

January 02, 2024

Understanding the Role of Cancer and Myositis

Johns Hopkins rheumatologist Lisa Christopher-Stine shares what is known about how the disease processes of cancer and myositis intertwine.

Johns Hopkins Medicine

June 21, 2023

ASCO 2023: Treating NUT Carcinoma Research Presented by Jia Luo, MD

Dana-Farber's Jia Luo, MD, details on findings from the NUT Carcinoma Registry on initial chemotherapy for locally advanced and metastatic disease.

Dana-Farber

February 13, 2023

Virtual Reality Has Laid Descartes’ Theory of Mind-Body Dualism to Rest

A key concept for which 17th century philosopher René Descartes is remembered is that of mind-body dualism: the belief that the immaterial mind and the physical body are two entirely distinct entities made of contrasting substances.

Cedars-Sinai Pulse

July 14, 2023

Scientists Discover a Deadly Brain Cancer’s Hidden Weakness

The difficult-to-treat brain cancer glioblastoma steals a person’s mental faculties as it spreads, yet the tumor’s insidious ability to infiltrate distant networks in the brain could also prove its undoing.

UCSF MedConnection